We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CRISPR Reveals New Targets for Promising Cancer Drugs

News   Jul 20, 2017 | Original story from Harvard University

 
CRISPR Reveals New Targets for Promising  Cancer Drugs

redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had essential immune evasion genes knocked out.

 
 
Advertisement
 

RELATED ARTICLES

Prevalence of Coronavirus Antibodies Declining in England

News

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

Even After a Deep Clean, Drug-Resistant Bacteria Can Persist

News

In immunocompromised patients, Enterococcus faecium can lead to potentially life-threatening infection. A team of scientists at the University of Cambridge and the London School of Hygiene and Tropical Medicine has pioneered an approach combining epidemiological and genomic information to chart the spread of bacteria within healthcare settings.

READ MORE

Large Screen Identifies New COVID-19 Related Genes

News

Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified genes that both enable the viruses to replicate in cells and those that may prevent it.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE